Dupuytren's Contracture and Lederhose Disease

Radiation therapy is an effective option for non-cancerous conditions including Dupuytren’s contracture and Ledderhose’s disease.

Ackerman Cancer Center uses advanced radiation therapy technologies to treat Dupuytren’s contracture and Ledderhose’s disease, softening the tissue and relieving the symptoms.

Treatments

A variety of treatment options are available for Dupuytren’s contracture including surgery, needle aponeurotomy, collagen injection, steroid injections, cryosurgery, and radiation therapy.

Ackerman Cancer Center offers radiation therapy as a non-surgical treatment option. To treat Dupuytren’s, radiation is delivered directly to the diseased tissue daily for five days in a row, followed by a treatment-free period ranging from six to 12 weeks. Finally, an additional series of five treatments is administered.

The radiation works to soften the affected tissue and restore function. It also helps prevent future contraction of the cords or nodules from forming. Treatment is most effective in the early stages of the disease, but may also be beneficial in later disease.

The board-certified radiation oncologists at Ackerman Cancer Center work closely with each patient to develop a radiation treatment plan designed to produce optimal results for patients with Dupuytren’s and Ledderhose.

What to Expect

For more information about the non-cancerous conditions treated at Ackerman Cancer Center, please contact us at 904-880-5522, or click here to learn what to expect during your treatment. 

Visit our wellness calendar to find out about upcoming support programs at Ackerman Cancer Center.

Talking Health

Catch Dr. Ackerman's latest interview on News4Jax about the differences between the flu and COVID-19.

Talking Health

Blog

For this Wellness Wednesday, here is a modern Arugula recipe you’ll fall in love with as well as the science behind the superfood.

Blog

Instagram

See what's happening around Ackerman on Instagram.

Instagram

Facebook

Like us on Facebook for all the newest info from our cutting-edge cancer center.

Facebook